PepLib
PepLib is a biotech company specializing in peptide drug discovery, leveraging its cutting-edge platform that includes PICT, disulfide-rich peptide phage display, and a machine learning–driven in silico design platform to accelerate the discovery of peptides with high affinity and specificity. PepLib’s pipeline features over 30 innovative peptide radioligands targeting tumor-specific markers such as FAP, GPC3, Trop2, and DLL3. With a flexible partnership model, PepLib actively seeks collaborations or opportunities to out-license its therapeutic assets.
